Clinical Trial Update: MPS II Immunophenotyping

View source ↗

Summary

A Duke University-sponsored trial investigating immunophenotyping in mucopolysaccharidosis type II (Hunter syndrome) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Ii

Snippet

Sponsor: Duke University | Conditions: MPS II, Mucopolysaccharidosis II | Status: TERMINATED